HomeIMM • LON
add
ImmuPharma PLC
Previous close
GBX 5.50
Day range
GBX 5.10 - GBX 7.40
Year range
GBX 0.82 - GBX 7.40
Market cap
25.40M GBP
Avg Volume
12.23M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 382.11K | -44.15% |
Net income | -193.93K | 54.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -372.69K | 38.50% |
Effective tax rate | 34.79% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.08M | 414.97% |
Total assets | 4.06M | 23.54% |
Total liabilities | 1.37M | -11.58% |
Total equity | 2.69M | — |
Shares outstanding | 416.44M | — |
Price to book | 5.50 | — |
Return on assets | -23.51% | — |
Return on capital | -35.50% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -193.93K | 54.23% |
Cash from operations | -438.36K | -34.28% |
Cash from investing | 739.77K | 100,961.61% |
Cash from financing | 146.69K | 58.72% |
Net change in cash | 437.98K | 291.58% |
Free cash flow | -214.04K | 2.02% |
About
Founded
1999
Website
Employees
5
